Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Studies of Chemopreventive Agents, Workstatement 37-261995037
Fox Chase Cancer Center, Philadelphia, PA, United States
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Light-activated oligonucleotides for biological applications
IntelliWheels: The Automatic Transmission for Manually Propelled Wheelchairs
The role of AF10 in normal and leukemic hematopoiesis
Genetics of Segregation Distortion in Drosophila
How the Locus Coeruleus Regulates the Spread of Seizures
Recently added grants:
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease
KLF control of aging and age-associated cardiovascular disease
Thrombospondin 4 Regulates Adaptive ER Stress Response
The Role of Osteopontin-OGDHL Axis in HFpEF
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095037-004
Application #
6688606
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Publications
Bellacosa, Alfonso; Godwin, Andrew K; Peri, Suraj et al.
(2010)
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.
Cancer Prev Res (Phila) 3:48-61
Comments
Be the first to comment on this grant